Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with melphalan.
Gris
J C
JC
Schved
J F
JF
Arnaud
A
A
Chauvet
C
C
D000208:Acute Disease; D005260:Female; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D008558:Melphalan / Q000009:adverse effects*; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000139:chemically induced*; D013920:Thrombocythemia, Essential / Q000188:drug therapy*
D008558:Melphalan